UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Invesco LLC

Invesco LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,861 shares of the healthcare conglomerate’s stock after acquiring an additional 240 shares during the period. Invesco LLC’s holdings in UnitedHealth Group were worth $1,088,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of UNH. BluePath Capital Management LLC raised its holdings in UnitedHealth Group by 11.8% in the third quarter. BluePath Capital Management LLC now owns 1,900 shares of the healthcare conglomerate’s stock valued at $1,111,000 after buying an additional 200 shares during the period. Chicago Partners Investment Group LLC grew its position in shares of UnitedHealth Group by 3.2% during the third quarter. Chicago Partners Investment Group LLC now owns 3,072 shares of the healthcare conglomerate’s stock worth $1,734,000 after buying an additional 94 shares in the last quarter. Phillips Wealth Planners LLC grew its position in shares of UnitedHealth Group by 4.7% during the third quarter. Phillips Wealth Planners LLC now owns 2,650 shares of the healthcare conglomerate’s stock worth $1,514,000 after buying an additional 120 shares in the last quarter. Farther Finance Advisors LLC boosted its holdings in UnitedHealth Group by 2.7% in the third quarter. Farther Finance Advisors LLC now owns 12,531 shares of the healthcare conglomerate’s stock worth $7,327,000 after purchasing an additional 332 shares during the period. Finally, Kearns & Associates LLC acquired a new position in UnitedHealth Group in the third quarter worth $219,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. KeyCorp began coverage on UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price on the stock. Morgan Stanley lowered their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their price target for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Finally, TD Cowen lifted their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded up $3.06 on Friday, reaching $567.56. The company’s stock had a trading volume of 2,548,368 shares, compared to its average volume of 3,259,068. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The company has a market cap of $524.10 billion, a price-to-earnings ratio of 36.97, a PEG ratio of 1.66 and a beta of 0.58. The business’s fifty day moving average price is $581.96 and its 200 day moving average price is $541.50. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the prior year, the firm posted $6.56 earnings per share. The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. Equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.48%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.